PLCD1 has been confirmed to play a cancer suppressive effect in colorectal cancer [20], gastric cancer [21], esophageal squamous carcinoma [22], pancreatic cancer [23], breast cancer [24], chronic myeloid leukemia [25]. This evidence concerns the gene PLCD1 and chronic myelogenous leukemia, BCR-ABL1 positive.